ANNALILY WILLIAMS: Open Payments
NPI 1194215798 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 82 payments from 12 companies in 2025. Trend: 2023 $1,079 · 2024 $1,114 · 2025 $1,343
Food & beverage: $1,253Education: $90
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $373 |
| ABBVIE INC. | 27 | $279 |
| Neurocrine BioSciences, Inc. | 14 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Alkermes, Inc. | 5 | $95 |
| Lundbeck LLC | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| ACADIA Pharmaceuticals Inc | 1 | $32 |
| Indivior Inc. | 1 | $19 |
Products named: VRAYLAR, INGREZZA, AUSTEDO XR, UZEDY, CAPLYTA, REXULTI, ARISTADA, LYBALVI.
Industry payments across SC — which companies pay providers there.
